FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction

Autor: Ture Lange Nielsen, Louis Lind Plesner, Peder Emil Warming, Ole Hartvig Mortensen, Kasper Karmark Iversen, James Goya Heaf

Publikováno v: Nefrología (English Edition), Vol 39, Iss 3, Pp 258-268 (2019)

Background: Fibroblast growth factor 23 (FGF23) is known to cause left ventricular hypertrophy (LVH), but controversy exists concerning its effect in dialysis. This study evaluated associations between FGF23 levels, echocardiography and prognosis in

Externí odkaz: https://doaj.org/article/c6581516805847f2960147c04ddcff2d

Putting AI to the Chest: Detection of Airspace Disease, Pneumothorax, and Pleural Effusion with Four Commercially Available AI Tools in the Copenhagen Smartchest Cohort

Autor: Louis Lind Plesner, Felix Christoph Müller, Mathias Willadsen Brejnebøl, Lene Collatz Laustrup, Finn Rasmussen, Olav W. Nielsen, Mikael Ploug Boesen, Michael Brun Andersen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8f0ccacd7bd4fcd1bc93d9158a359210
https://doi.org/10.2139/ssrn.4429020

Mid-regional pro-atrial natriuretic peptide predicts cardiovascular mortality in patients undergoing hemodialysis

Autor: Rasmus Bo Hasselbalch, Ture Lange Nielsen, Henning Bundgaard, Louis Lind Plesner, Jonas H Kristensen, Jens P. Goetze, Kasper Iversen

Publikováno v: European Heart Journal. 41

Background Cardiovascular diseases are major contributors to morbidity and mortality among patients with renal disease. Mid-regional pro-atrial natriuretic peptide (MR-proANP) is a fragment of the precursor molecule of atrial natriuretic peptide, a h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71ee121ec52e498a0d412e594279e95c
https://doi.org/10.1093/ehjci/ehaa946.3315

Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study

Autor: Peder Emil Warming, Casper Rydahl, Mads Ersbøll, Morten Dalsgaard, Kasper Iversen, Ture Lange Nielsen, Anna Axelsson Raja, Lisbet Brandi, Morten Schou, Louis Lind Plesner

Publikováno v: Axelsson Raja, A, Warming, P E, Nielsen, T L, Plesner, L L, Ersbøll, M, Dalsgaard, M, Schou, M, Rydahl, C, Brandi, L & Iversen, K 2020, ' Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis : An observational study ', BMC Nephrology, vol. 21, no. 1, 413 . https://doi.org/10.1186/s12882-020-02074-3
BMC Nephrology, Vol 21, Iss 1, Pp 1-9 (2020)
BMC Nephrology

Background Cardiovascular disease is the most common cause of death in patients with end-stage kidney disease on haemodialysis. The potential clinical consequence of systematic echocardiographic assessment is however not clear. In an unselected, cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54546454afa2577378d5a454a5ae9832
https://doi.org/10.1186/s12882-020-02074-3

Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids

Autor: Jon J Rasmussen, Jens Faber, Morten Schou, Louis Lind Plesner, Per Lav Madsen, Caroline Kistorp, Marie Lindhardt Johansen, Finn Gustafsson, Thomas Kümler, Tina Dreyer, Christian Selmer, Peter S. Ulriksen

Publikováno v: American Heart Journal. 203:49-56

Illicit use of anabolic androgenic steroids (AAS) is associated with left ventricle (LV) systolic dysfunction and increased LV mass (LVM), but whether these findings persist in former AAS users has yet to be elucidated. The objective was to assess LV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44dffb3a90cb04433ea859627675558b
https://doi.org/10.1016/j.ahj.2018.06.010